GE HealthCare Technologies Stock

$74.02

1.60% today

Nasdaq, Aug 25, 05:53 pm CET

ISIN

US36266G1076

Symbol

GEHC

Reports

Quarter | Annual

Index

NASDAQ-100, S&P 500

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Overview Dividends Analysts Charts News Strategies

GE HealthCare Technologies Stock price

$75.22

+15.22 25.37% 5Y

Nasdaq, Closing price Fri, Aug 22 2025

+2.07 2.83%

ISIN

US36266G1076

Symbol

GEHC

Reports

Quarter | Annual

Index

NASDAQ-100, S&P 500

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Key metrics

Basic

Market capitalization

$34.3b

Enterprise Value

$40.9b

Net debt

$6.6b

Cash

$3.7b

Shares outstanding

456.6m

Valuation (TTM | estimate)

P/E

15.4 | 16.3

P/S

1.7 | 1.6

EV/Sales

2.1 | 2.0

EV/FCF

26.1

P/B

3.5

Dividends

DPS

$0.12

Yield 1Y | 5Y

0.2% | 0.1%

Growth 1Y | 5Y

33.3% | -

Payout 1Y | 3Y

2.8% | 1.8%

Increased

2 Years

Financials (TTM | estimate)

Revenue

$20.0b | $20.9b

EBITDA

$3.3b | $3.5b

EBIT

$2.8b | $3.0b

Net Income

$2.2b | $2.1b

Free Cash Flow

$1.6b

Growth (TTM | estimate)

Revenue

2.3% | 6.1%

EBITDA

9.2% | 10.3%

EBIT

12.5% | 15.7%

Net Income

41.8% | 5.7%

Free Cash Flow

-3.2%

Financial Health

Equity Ratio

25.5%

Return on Equity

23.6%

ROCE

10.7%

ROIC

8.9%

Debt/Equity

1.1

EPS

$4.9

FCF per Share

$3.4

Short interest

2.6%

Employees

53k

Rev per Employee

$370.0k

Set up alerts on Stock Price, Dividend Yield, Valuation (e.g. P/E or EV/Sales) or Strategy Scores and sit back and relax.

GE HealthCare Technologies Stock Analysis

Unlock Scores for Free

27 Analysts have issued a GE HealthCare Technologies forecast:

20x Buy

74%

7x Hold

26%

More details on Analyst Estimates Including Price Targets

27 Analysts have issued a GE HealthCare Technologies forecast:

Buy

74%

Hold

26%

Analyst Estimates with Stock Price Targets

Financial data from GE HealthCare Technologies

Income Statement P&L | Balance Sheet | Cash Flow

Quarter TTM Annually

Jun '25		+/- %
Revenue	19,966 19,966	2% 2% 100%
- Direct Costs	11,670 11,670	1% 1% 58%
Gross Profit	8,296 8,296	4% 4% 42%
- Selling and Administrative Expenses	4,233 4,233	0% 0% 21%
- Research and Development Expense	1,306 1,306	1% 1% 7%
EBITDA	3,327 3,327	9% 9% 17%
- Depreciation and Amortization	567 567	5% 5% 3%
EBIT (Operating Income) EBIT	2,760 2,760	12% 12% 14%
Net Profit	2,241 2,241	42% 42% 11%

In millions USD.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Subscribe Now

GE HealthCare Technologies Stock News

Neutral

Business Wire

●

4 days ago

GE HealthCare management to present at upcoming investor conferences

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) is announcing that members of its management team will present at the following upcoming investor conferences. 2025 Wells Fargo Healthcare Conference – Thursday, September 4, 2025 at 8:45 am ET/7:45 am CT Morgan Stanley 23rd Annual Global Healthcare Conference – Tuesday, September 9, 2025 at 9:15 am ET/8:15 am CT Webcasts of these events ca...

Positive

Seeking Alpha

●

25 days ago

GE HealthCare: This Drop Represents A Buying Opportunity

GE HealthCare Technologies delivered strong Q2 results, beating revenue and earnings expectations, and raised full-year guidance despite a sharp share price drop. The company is trading at a significant discount to peers, offering substantial upside potential even at the low end of industry valuation multiples. Management is actively mitigating tariff impacts, investing in innovation, and launc...

Neutral

Seeking Alpha

●

26 days ago

GE HealthCare Technologies Inc. (GEHC) Q2 2025 Earnings Call Transcript

GE HealthCare Technologies Inc. (NASDAQ:GEHC ) Q2 2025 Earnings Conference Call July 30, 2025 8:30 AM ET Company Participants Carolynne Borders - Chief Investor Relations Officer James K. Saccaro - VP & CFO Peter J.

More GE HealthCare Technologies News

Company Profile

GE Healthcare Technologies, Inc. operates as a holding company with interest in providing medical technology, pharmaceutical diagnostics and digital solutions. Its operating segments include Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company was founded on May 16, 2022 and is headquartered in Chicago, IL.

Head office	United States
CEO	Peter Arduini
Employees	53,000
Founded	2022
Website	www.gehealthcare.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now